JP2008519761A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519761A5
JP2008519761A5 JP2007540066A JP2007540066A JP2008519761A5 JP 2008519761 A5 JP2008519761 A5 JP 2008519761A5 JP 2007540066 A JP2007540066 A JP 2007540066A JP 2007540066 A JP2007540066 A JP 2007540066A JP 2008519761 A5 JP2008519761 A5 JP 2008519761A5
Authority
JP
Japan
Prior art keywords
amino
carbonyl
trimethylphenyl
cyclohexyl
naphthalenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007540066A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008519761A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/039956 external-priority patent/WO2006052722A1/en
Publication of JP2008519761A publication Critical patent/JP2008519761A/ja
Publication of JP2008519761A5 publication Critical patent/JP2008519761A5/ja
Pending legal-status Critical Current

Links

JP2007540066A 2004-11-09 2005-11-04 グリコーゲンホスホリラーゼ阻害化合物およびその医薬組成物 Pending JP2008519761A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62638904P 2004-11-09 2004-11-09
PCT/US2005/039956 WO2006052722A1 (en) 2004-11-09 2005-11-04 Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof

Publications (2)

Publication Number Publication Date
JP2008519761A JP2008519761A (ja) 2008-06-12
JP2008519761A5 true JP2008519761A5 (https=) 2008-10-16

Family

ID=35976487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007540066A Pending JP2008519761A (ja) 2004-11-09 2005-11-04 グリコーゲンホスホリラーゼ阻害化合物およびその医薬組成物

Country Status (16)

Country Link
US (1) US20070249670A1 (https=)
EP (1) EP1812383A1 (https=)
JP (1) JP2008519761A (https=)
KR (1) KR20070086044A (https=)
CN (1) CN101098852A (https=)
AU (2) AU2005304962B2 (https=)
BR (1) BRPI0517567A (https=)
CA (1) CA2586446A1 (https=)
IL (1) IL182863A0 (https=)
MA (1) MA29090B1 (https=)
MX (1) MX2007005590A (https=)
NO (1) NO20072223L (https=)
RU (1) RU2007119427A (https=)
SG (1) SG155229A1 (https=)
WO (1) WO2006052722A1 (https=)
ZA (1) ZA200703713B (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4770213B2 (ja) * 2004-03-22 2011-09-14 住友化学株式会社 (2−ホルミル−1−アルケニル)シクロプロパン化合物の製造方法
EP1676834A1 (en) 2004-12-30 2006-07-05 Sanofi-Aventis Deutschland GmbH Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
JP5352454B2 (ja) 2006-06-28 2013-11-27 サノフイ Cxcr2アンンタゴニスト
EP2040690B1 (en) 2006-06-28 2014-08-06 Sanofi Inhibitors of cxcr2
CA2656150A1 (en) 2006-06-28 2008-01-03 Sanofi-Aventis New cxcr2 inhibitors
JP5352455B2 (ja) * 2006-06-30 2013-11-27 サノフイ Cxcr2阻害剤
GB0619611D0 (en) * 2006-10-04 2006-11-15 Ark Therapeutics Ltd Compounds and their use
DE102007012284A1 (de) 2007-03-16 2008-09-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035333A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035334A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
KR20100087300A (ko) * 2007-09-28 2010-08-04 글락소스미스클라인 엘엘씨 글리코겐 포스포릴라아제 억제제 화합물 및 이의 약학적 조성물
CN101861303A (zh) * 2007-09-28 2010-10-13 葛兰素史密丝克莱恩有限责任公司 糖原磷酸化酶抑制剂化合物和其药物组合物
PT2303270T (pt) * 2008-05-05 2017-08-25 Sanofi Sa Derivados fundidos do ácido ciclopentanocarboxílico substituídos por acilamino e sua utilização como produtos farmacêuticos
EP2299816B1 (en) * 2008-06-18 2013-11-13 Merck Sharp & Dohme Corp. Inhibitors of janus kinases
WO2010092440A1 (en) * 2009-02-16 2010-08-19 Inserm (Institut National De La Sante Et De La Recherche Medicale) Cxcr2 receptor antagonists for the treatment or the prevention of insulin resistance
AR079022A1 (es) * 2009-11-02 2011-12-21 Sanofi Aventis Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
US8729114B2 (en) 2010-03-05 2014-05-20 Boehringer Ingelheim International Gmbh Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-S
WO2011159781A2 (en) * 2010-06-17 2011-12-22 Senomyx, Inc. Bitter taste modulators
GB201211309D0 (en) * 2012-06-26 2012-08-08 Fujifilm Mfg Europe Bv Process for preparing membranes
HUE032306T2 (en) 2012-06-26 2017-09-28 Bayer Pharma AG N- [4- (quinolin-4-yloxy) cyclohexyl (methyl)] (hetero) arylcarboxamides as androgen receptor antagonists, their production and use as pharmaceutical products
MX388871B (es) 2014-06-27 2025-03-20 Nogra Pharma Ltd Moduladores del receptor arilo y metodos para elaborar y usar los mismos.
EP3426674A4 (en) 2016-03-09 2019-08-14 Blade Therapeutics, Inc. CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
AU2017292646A1 (en) 2016-07-05 2019-02-07 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
WO2018064119A1 (en) 2016-09-28 2018-04-05 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
EP3762379A1 (en) 2018-03-07 2021-01-13 Bayer Aktiengesellschaft Identification and use of erk5 inhibitors
SG11202106444WA (en) 2018-12-19 2021-07-29 Leo Pharma As Amino-acid anilides as small molecule modulators of il-17
WO2020234103A1 (en) 2019-05-21 2020-11-26 Bayer Aktiengesellschaft Identification and use of kras inhibitors
WO2021152113A1 (en) 2020-01-31 2021-08-05 Bayer Aktiengesellschaft Substituted 2,3-benzodiazepines derivatives

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59181257A (ja) * 1983-03-31 1984-10-15 Chugai Pharmaceut Co Ltd ウレイドベンズアミド誘導体
JPS61268678A (ja) * 1985-05-17 1986-11-28 バイエル・アクチエンゲゼルシヤフト 生産増進剤
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity
BR9611820A (pt) * 1995-11-24 1999-07-13 Smithkline Beecham Spa Derivados de quinolina
CA2255858C (en) * 1996-05-24 2007-09-11 Neurosearch A/S Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
DE69826695T2 (de) * 1997-05-23 2006-02-02 Bayer Pharmaceuticals Corp., West Haven Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
US6093742A (en) * 1997-06-27 2000-07-25 Vertex Pharmaceuticals, Inc. Inhibitors of p38
US7125875B2 (en) * 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
ES2288871T3 (es) * 1999-09-24 2008-02-01 Genentech, Inc. Derivados de tirosina.
GB0008264D0 (en) * 2000-04-04 2000-05-24 Smithkline Beecham Plc Novel method and compounds
US20040023961A1 (en) * 2002-02-11 2004-02-05 Bayer Corporation Aryl ureas with raf kinase and angiogenisis inhibiting activity
AU2003265398A1 (en) * 2002-08-09 2004-02-25 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
AU2003258491A1 (en) * 2002-09-05 2004-03-29 Neurosearch A/S Amide derivatives and their use as chloride channel blockers
PT1565429E (pt) * 2002-11-21 2009-07-23 Neurosearch As Derivados de diaril-ureído e sua utilização médica
WO2005023818A2 (en) * 2003-09-10 2005-03-17 Gpc Biotech Ag Heterobicyclic compounds as pharmaceutically active agents
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
CA2563432A1 (en) * 2004-04-16 2005-12-01 Genentech, Inc. Method for augmenting b cell depletion

Similar Documents

Publication Publication Date Title
JP2008519761A5 (https=)
RU2007119427A (ru) Соединения, являющиеся ингибиторами гликогенфосфорилазы, и фармацевтические композиции на их основе
RU2215735C2 (ru) Производные аминомасляной, аминопентановой и аминогексановой кислот
RU2312860C2 (ru) Циклические ингибиторы протеинтирозинкиназ
RU2203897C2 (ru) Производные бензамидина, способ их получения, фармацевтическая композиция, способ ее получения и лекарственное средство
RU2001126559A (ru) Активаторы глюкокиназы
JP2005511746A5 (https=)
JP2004502670A5 (https=)
RU2006123418A (ru) Новые антагонисты м3 мускаринового ацетилхолинового рецептора
JP2014511869A5 (https=)
JP2004532187A5 (https=)
JP2004534035A5 (https=)
AR048306A1 (es) Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40
JP2004509953A5 (https=)
RU2002128733A (ru) МОДУЛЯТОРЫ PPARγ
JP2009520686A5 (https=)
JP2015509543A5 (https=)
JP2004523490A5 (https=)
RU2009108275A (ru) Соединение сульфонамида или его соль
JP2011500679A5 (https=)
RU2006124403A (ru) Новые производные тиазола
JP2013506637A5 (https=)
RU2006129297A (ru) Производные n-(1,5-дифенил-1н-пиразол-3-ил)сульфонамида со сродством к рецепторам cb1
RU2015101210A (ru) Производные тиофена, используемые для лечения сахарного диабета
US20050124656A1 (en) Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)